Regulatory Filings and Submissions

>

Latest News

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
FDA Approves Pfizer Combination Regimen for Treating R/R Diffuse Large B-Cell Lymphoma

February 14th 2025

The approval of an ADCETRIS combination regimen is based on positive data from a Phase III trial where the combination regimen demonstrated a clinically meaningful reduction in the risk of death.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Voyager Pauses IND Filing while Assessing Alternate Payloads for SOD1 ALS Gene Therapy Program

February 13th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
FDA Grants Orphan Drug Designation to March Biosciences for T-Cell Lymphoma Cell Therapy

February 11th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Genentech’s Susvimo Gets FDA Nod as Continuous Delivery Treatment for Diabetes-Related Blindness

February 7th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
CHMP Recommends Imfinzi for Approval in EU for Limited-Stage Small Cell Lung Cancer

February 5th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.